Pfizer reports second quarter revenue of $15.03 billion, compared to an estimate of $14.41 billion. Adjusted earnings per share for the second quarter are $0.77. Pfizer expects full-year revenue between $60.5 billion and $62.5 billion, with the market estimate at $61.76 billion.

Pfizer reports second quarter revenue of $15.03 billion, compared to an estimate of $14.41 billion. Adjusted earnings per share for the second quarter are $0.77. Pfizer expects full-year revenue between $60.5 billion and $62.5 billion, with the market estimate at $61.76 billion.

智通财经2026/08/04 10:56

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pfizer's second quarter revenue reached $15.03 billion, exceeding the estimate of $14.41 billion. Adjusted earnings per share for the second quarter were $0.77. Pfizer expects full-year revenue to range from $60.5 billion to $62.5 billion, with the market estimate at $61.76 billion.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pfizer reports second quarter revenue of $15.03 billion, compared to an estimate of $14.41 billion. Adjusted earnings per share for the second quarter are $0.77. Pfizer expects full-year revenue between $60.5 billion and $62.5 billion, with the market estimate at $61.76 billion.

You may also like

Crypto prices